Zanotta N, Campisciano G, Scrimin F, Blendi U, Marcuzzi A, Vincenti E, Crovella S, Comar M. Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets. Eur J Obstet Gynecol Reprod Biol 2018;226:66-70.

Toson B, Santos EJosé Dos, Adelino JEduardo, Sandrin-Garcia P, Crovella S, Louzada-Júnior P, Oliveira RDonizete R, Pedroza LSanta Rosa, Sauma Mde Fátima, de Lima CPereira Si, Barbosa FBrasil, Brenol CViegas, Xavier RMachado, Chies JArtur Bogo, Veit TDegani. CCR5?32 and the genetic susceptibility to rheumatoid arthritis in admixed populations: a multicentre study. Rheumatology (Oxford) 2017;56(3):495-497.

Santos EUbirajara, de Lima GDayane Cor, Oliveira Mde Lucena, Heráclio Sde Andrade, da Silva HDornelas A, Crovella S, Maia Mde Mascena, de Souza PRoberto El. CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study. Mem Inst Oswaldo Cruz 2016;111(3):174-80.

Zupin L, Polesello V, Alberi G, Moratelli G, Crocè SLory, Masutti F, Pozzato G, Crovella S, Segat L. CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response. Mol Immunol 2016;76:49-54.

da Silva RCelerino, Coelho AVictor Cam, Arraes LCláudio, Brandão LAndré Cav, Guimarães RLima, Crovella S. Chemokines SNPs in HIV-1+ Patients and Healthy Controls from Northeast Brazil: Association with Protection against HIV-1 Infection. Curr HIV Res 2016;14(4):340-5.

Santos Rde Luna Al, Crovella S, Celsi F. Comment to Santos et al., "hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype". Gene 2015;559(1):99-101.

Bianco AMonica, Zanin V, Marcuzzi A, Crovella S. Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. Cell Biochem Funct 2012;30(2):176.

Vuch J, Marcuzzi A, Zanin V, Crovella S. Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. Toxicology 2012;293(1-3):123-4.

Bianco AMonica, Zanin V, Girardelli M, Magnolato A, Martelossi S, Martellossi S, Tommasini A, Marcuzzi A, Crovella S. A common genetic background could explain early-onset Crohn's disease. Med Hypotheses 2012;78(4):520-2.

Marcuzzi A, Zanin V, Crovella S, Pontillo A. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). Oral Oncol 2011;47(5):436-7; author reply 438.